Recurrent Sacral Chordoma Treated by Radiotherapy: A Case Report

Chordoma is a rare and locally aggressive tumor that arises from the notochordal remnants that corresponds to 1 to 4 % of all malignant bone tumors in the axial skeleton, and has an incidence of 0.1/100000 per year. It consists of a silent and slow-growing mass that requires radical treatment due to its high potential for local and metastatic invasion. It is typically managed with surgery in combination with radiation therapy. The risk of recurrence is very high due to the infiltrating nature of the tumor. A favorable outcome depends on early diagnosis and surgical resection with tumor-free margins. It can arise along the ventromedial aspect of the sacrum, mobile spine, and clivus, with most cases occurring in the sacrum or skull base. We report a case of a 56-years male who complained of pain over his sacral region for the past three years and constipation with no neurological signs. Eighteen months after undergoing large surgery resection for his sacral chordoma with no adjuvant treatment. He was then diagnosed with recurrent sacral chordoma and planned for radiotherapy given the possible complications after surgery.

Authors

Publication Details

Journal
Scholars Journal of Medical Case Reports
Published
2024-09-23
DOI
https://doi.org/10.36347/sjmcr.2024.v12i09.023
Primary Topic
Bone Tumor Diagnosis and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrent Sacral Chordoma Treated by Radiotherapy: A Case Report

M. Darfaoui, M. Khouchani, A. El Omrani, S. Laatitioui et al.
Scholars Journal of Medical Case Reports
Bone Tumor Diagnosis and Treatments
article

Recurrent Sacral Chordoma Treated by Radiotherapy: A Case Report

M. Darfaoui, M. Khouchani, A. El Omrani, S. Laatitioui, M. Saadoune, N. Oumghar, S. Berkich, S. E. Marzouq, H. Kassar
article en

Abstract

Chordoma is a rare and locally aggressive tumor that arises from the notochordal remnants that corresponds to 1 to 4 % of all malignant bone tumors in the axial skeleton, and has an incidence of 0.1/100000 per year. It consists of a silent and slow-growing mass that requires radical treatment due to its high potential for local and metastatic invasion. It is typically managed with surgery in combination with radiation therapy. The risk of recurrence is very high due to the infiltrating nature of the tumor. A favorable outcome depends on early diagnosis and surgical resection with tumor-free margins. It can arise along the ventromedial aspect of the sacrum, mobile spine, and clivus, with most cases occurring in the sacrum or skull base. We report a case of a 56-years male who complained of pain over his sacral region for the past three years and constipation with no neurological signs. Eighteen months after undergoing large surgery resection for his sacral chordoma with no adjuvant treatment. He was then diagnosed with recurrent sacral chordoma and planned for radiotherapy given the possible complications after surgery.

Scholars Journal of Medical Case ReportsVol. 12(09)
Openalex Percentile: Top 71%
Bone Tumor Diagnosis and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recurrent Sacral Chordoma Treated by Radiotherapy: A Case Report — M. Darfaoui, M. Khouchani, et al. · Scholars Journal of Medical Case Reports (2024) | TGRS Research Map | TGRS